OP0085 Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease (SSc-ILD): results from an EUSTAR cohort study

Benfaremo, D., Campochiaro, C., Kumanovics, G. et al. (16 more authors) (2025) OP0085 Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease (SSc-ILD): results from an EUSTAR cohort study. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. , p. 75. ISSN: 0003-4967 EISSN: 1468-2060

Metadata

Item Type: Proceedings Paper
Authors/Creators:
  • Benfaremo, D.
  • Campochiaro, C.
  • Kumanovics, G.
  • Bergmann, C.
  • Zanatta, E.
  • Launay, D.
  • Guiducci, S.
  • Martin, M.
  • Muller, C.S.
  • Montecucco, C.
  • Mouthon, L.
  • Szucs, G.
  • Kastrati, K.
  • Truchetet, M.E.
  • Vonk, M.
  • Del Galdo, F. ORCID logo https://orcid.org/0000-0002-8528-2283
  • Matucci-Cerinic, M.
  • Moroncini, G.
  • Allanore, Y.
Dates:
  • Accepted: 26 March 2025
  • Published (online): 18 June 2025
  • Published: June 2025
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 31 Jul 2025 14:16
Last Modified: 01 Aug 2025 11:06
Status: Published
Identification Number: 10.1016/j.ard.2025.05.107
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)